You are signed out
Join Innoget to connect with Dr. Thomas Kallimopoulos and thousands
of innovation-driven professionals and organizations
Summary
Elaboration of platform technologies for sustainable production of active pharmaceutical ingredients (API) from biomass and using sustainable ressources, respectful to the environment and clima change.
Development of natural products as drugs against addiction and pain management.
Work Experience (4)
R&D, Manufacturing Chemist, Marketing Manager
Givaudan SA
January 1991 - December 1996
Geneva
General Manager
GK Amenities
December 1996 - January 2001
Geneva
Marketing Manager
BASF
June 2001 - February 2009
Founding Partner
Extranthis UG (DE) & CORYN Pharmaceuticals LLC (USA)
February 2009 - Present
Ludwigshafen
Academic Studies (5)
Chemical Engineer
University of Neuchâtel - Switzerland
January 1980 - January 1983
Chemistry
PhD
University of Neuchâtel - Switzerland
January 1983 - January 1987
Organic Chemistry
Post-doc studies
University of Neuchâtel - Switzerland
January 1987 - January 1988
Organic Synthesis
Research Associate
Columbia University NY - USA
January 1988 - January 1989
Neurochemistry
Research Associate
University of Neuchâtel - Switzerland
January 1989 - January 1991
Organic Synthesis
Research areas of interest (4)
- Biological Sciences
- Medicine, Human Health
- Neurology, Brain Research
- Pharmaceutical Products / Drugs
Dr. Thomas Kallimopoulos didn't publish any Technology Call yet
1. Synthèse des (1)-(6R)- et (+)-(6S)-tétrahydro-6-[(Z)-pent-2-ényl]-2H-pyran-2-one, lactones de Jasminum grandiflorum L.- et de Polianthes tuberosa L.. Helv. Chim. Acta. 74, 787¬790, (1991).
see publication
2. Synthèse énantiospécifique du (1)-(1S,3R,5R)-1,8-diméthyl-3-éthyl-2,9-dioxabicyclo [3.3.1]non-7-ène. Helv. Chim. Acta, 74, 1233-1235, (1991).
see publication
3. Structure-activity relationships of Philanthotoxin analogs and polyamines on N-Méthyl-D-Aspartate and Nicotinic Acetylcholine receptors. Journal of Pharmacology and Experimental Therapeutics, 254, 764-773, (1990).
see publication
4. Structure - activity relationships of analogues of the wasp toxin Philanthotoxin : Non-competitive antagonists of quisqualate receptors. Toxicon, 28, 1333-1346, (1990).
see publication
5. Philanthotoxine-433, (PhTx-433), a non-competitive glutamate receptor inhibitor. Pure Appl. Chem., 62, 1223- 1230, (1990).
see publication
6. Synthesis of glutamate receptor antagonist Philanthotoxine-433 (PhTx-433) and its analogs. Tetrahedron 46, 3267-3286, (1990).
see publication
7. Synthèse énantiospécifique du (1)-(1R,3R,5S)-diméthyl-1,3-dioxa-2,9-bicyclo-[3.3.1] nonane. Helv. Chim. Acta, 72, 1284-1287, (1989).
see publication
8. Synthèse énantiospécifique de la (+)-(R)-éthyl-6-dihydro-2,3-méthyl-2-4H-pyranone-4, phéromone de la mite Hepialus Hecta L.. Helv. Chim. Acta, 72, 1259-1261, (1989).
see publication
9. Synthèse énantiospécifique des acides (+)-(2R) et (-)-(2S)-éthyl-6-dihydro-3,4-méthyl-2-oxo-4-2H- pyranecarboxylique-5. Helv. Chim. Acta, 72, 731-737, (1989).
see publication
10. Structure of 1,5-Di(1-pyrrodinyl)-4-hexene-1,3-dione. Acta Cryst., C43, 2155-2157, (1987).
see publication
11. EP2292629 Method of isolating cytisine from biomaterial.
see patent at European Patent Office database
12. WO2011026637 Methods for isolating alkaloids from plants.
see patent at the European Patent Office database
Dr. Thomas Kallimopoulos didn't publish any Event yet
Dr. Thomas Kallimopoulos didn't publish any Job yet
Dr. Thomas Kallimopoulos didn't publish any New and Article yet
Dr. Thomas Kallimopoulos didn't publish any Education Resource yet
